PATHOLOGY OF THE ADRENAL GLANDS

Pathological Features of Benign and Malignant Tumors of the Adrenal Gland

Benign Adrenal Tumors

Benign adrenal tumors are typically non-cancerous growths that can still cause health issues due to hormone overproduction or mass effects. The most common types include adrenal adenomas, benign pheochromocytomas, and benign paragangliomas.

1. Adrenal Adenomas:
   • These tumors are usually small (less than 4 cm) and well-circumscribed.
   • Histologically, they show a uniform population of cells with minimal nuclear atypia and a high nuclear-to-cytoplasmic ratio.
   • They often exhibit lipid-rich cytoplasm due to the accumulation of cholesterol.
   • Adenomas may be functioning (producing hormones) or non-functioning, with functioning adenomas commonly causing conditions like Cushing’s syndrome or hyperaldosteronism.
2. Benign Pheochromocytomas:
   • These tumors arise from chromaffin cells in the adrenal medulla and are characterized by their ability to produce catecholamines.
   • Pathologically, they appear as well-defined masses with nests of polygonal cells (Zellballen pattern).
   • They typically show moderate cellularity and pleomorphic nuclei but lack significant atypia or necrosis.
3. Benign Paragangliomas:
   • Similar to pheochromocytomas but can occur outside the adrenal gland.
   • They also display a Zellballen architecture and are composed of chief cells surrounded by sustentacular cells.
   • Like pheochromocytomas, they may produce catecholamines but are generally less aggressive.

Malignant Adrenal Tumors

Malignant adrenal tumors include adrenocortical carcinoma (ACC), malignant pheochromocytoma, and malignant paraganglioma. These tumors tend to have more aggressive behavior and poorer prognoses compared to benign counterparts.

1. Adrenocortical Carcinoma (ACC):
   • ACC is characterized by larger size (often greater than 5 cm) and irregular borders.
   • Histologically, it shows marked nuclear atypia, increased mitotic activity, necrosis, and invasion into surrounding tissues.
   • The Weiss score is commonly used for diagnosis post-surgery; it includes criteria such as tumor size, presence of necrosis, high mitotic rate, and atypical nuclei.
2. Malignant Pheochromocytoma:
   • These tumors can metastasize and often present with symptoms related to excess catecholamine production.
   • Pathological features include increased cellularity, nuclear atypia, necrosis, vascular invasion, and metastasis.
   • Unlike benign forms, malignant pheochromocytomas demonstrate significant histological variability.
3. Malignant Paraganglioma:
   • Similar in presentation to malignant pheochromocytoma but can arise from extra-adrenal sites as well.
   • They exhibit similar pathological features such as high cellularity, necrosis, vascular invasion, and metastatic potential.

In summary, distinguishing between benign and malignant adrenal tumors relies on careful histopathological examination that considers tumor architecture, cellular characteristics (such as nuclear atypia), mitotic activity, presence of necrosis or invasion into surrounding tissues.

Causes of Addison’s Disease and Their Pathological Features

Addison’s disease, also known as primary adrenal insufficiency, is characterized by the inadequate production of hormones cortisol and aldosterone due to damage to the adrenal glands. The causes of Addison’s disease can be categorized into several distinct categories, each with its own pathological features:

1. Autoimmune Destruction:
   • The most prevalent cause of Addison’s disease is autoimmune destruction of the adrenal cortex. In this condition, the immune system mistakenly attacks the adrenal glands, leading to a significant reduction in hormone production. This autoimmune response often results in inflammation and progressive damage to the adrenal tissue. It is estimated that approximately 75% of cases are due to this mechanism.
2. Infections:
   • Certain infections can lead to Addison’s disease by damaging the adrenal glands. Historically, tuberculosis (TB) was a leading cause; however, with advancements in treatment, its prevalence has decreased. TB can cause caseous necrosis in the adrenal glands, leading to their dysfunction. Other infections such as HIV/AIDS may also predispose individuals to adrenal insufficiency due to opportunistic infections that affect gland function.
3. Adrenal Hemorrhage:
   • Bleeding into the adrenal glands can occur due to various factors including trauma or anticoagulant therapy. This hemorrhage can lead to acute adrenal failure if a significant portion of glandular tissue is compromised.
4. Genetic Disorders:
   • Certain genetic conditions can affect the development or function of the adrenal glands, resulting in Addison’s disease. For example, congenital adrenal hyperplasia (CAH) involves enzyme deficiencies that impair steroidogenesis, potentially leading to insufficient cortisol production.
5. Tumors:
   • Malignancies affecting the adrenal glands can disrupt normal hormone production either through direct invasion or by causing secondary effects such as pressure on surrounding tissues or hormonal imbalances.
6. Surgical Removal:
   • Surgical procedures that involve removing one or both adrenal glands for other medical conditions can result in Addison’s disease due to loss of hormone-producing capacity.
7. Medications:
   • Certain medications, particularly long-term use of corticosteroids, can suppress natural cortisol production by feedback inhibition on the hypothalamus and pituitary gland, leading to secondary adrenal insufficiency which may manifest similarly to Addison’s disease when corticosteroid therapy is abruptly discontinued.
8. Tertiary Causes:
   • Tertiary adrenal insufficiency occurs when there is a lack of corticotropin-releasing hormone (CRH) from the hypothalamus due to prolonged suppression from exogenous glucocorticoids or after treatment for Cushing’s syndrome.

The pathological features associated with these causes typically include atrophy or destruction of the adrenal cortex with resultant deficiency in steroid hormones (cortisol and aldosterone), which leads to clinical manifestations such as fatigue, weight loss, hypotension, and electrolyte imbalances.

Classification of Multiple Endocrine Neoplasia

Multiple endocrine neoplasia (MEN) is classified into several types based on the specific genetic mutations involved, the endocrine glands affected, and the associated clinical features. The major forms of multiple endocrine neoplasia include:

1. Multiple Endocrine Neoplasia Type 1 (MEN1)

This type is characterized by tumors in at least three endocrine glands, primarily affecting the parathyroid glands, pituitary gland, and pancreas. The most common manifestation is hyperparathyroidism, which can lead to elevated calcium levels in the blood and associated complications such as kidney stones and osteoporosis.

2. Multiple Endocrine Neoplasia Type 2 (MEN2)

This type is further divided into three subtypes:

• Type 2A (MEN2A): Involves medullary thyroid carcinoma, pheochromocytoma (tumor of the adrenal gland), and hyperparathyroidism.
• Type 2B (MEN2B): Similar to MEN2A but also includes mucosal neuromas and a marfanoid habitus. It is less common than MEN2A.
• Familial Medullary Thyroid Carcinoma (FMTC): Characterized solely by medullary thyroid carcinoma without other features of MEN2A or MEN2B.

3. Multiple Endocrine Neoplasia Type 4 (MEN4)

This type shares similarities with MEN1 but is caused by mutations in a different gene (CDKN1B). It typically involves hyperparathyroidism and tumors in various endocrine glands.

In summary, multiple endocrine neoplasia can be classified into four main types: MEN1, MEN2 (with subtypes A, B, and FMTC), and MEN4, each with distinct genetic causes and clinical manifestations.